Early OpenAI backer Thrive Capital value hits $3.7B on fund growth, sees ‘billions in liquidity’: reportAugust 14, 2026
Share Facebook Twitter LinkedIn Pinterest Email CDC vaccine panel voting on hepatitis b shots postponed over confusion
Early OpenAI backer Thrive Capital value hits $3.7B on fund growth, sees ‘billions in liquidity’: reportAugust 14, 2026
Genasys signals fiscal 2026 record year outlook as it expects to complete initial $9M CROWS delivery within the year (NASDAQ:GNSS)August 14, 2026
